vs
McEwen Inc.（MUX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是McEwen Inc.的1.1倍（$69.8M vs $64.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 59.0%，领先325.0%），McEwen Inc.同比增速更快（92.8% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 25.2%）
McEwen Inc（股票代码MUX）是一家自然资源企业，主要从事金、银、铜矿产的勘探、开发与生产业务，运营项目分布于南北美洲，秉持可持续负责任的采矿准则，产品面向全球大宗商品市场供应。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MUX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$64.6M
营收增速更快
MUX
高出71.6%
21.2%
净利率更高
RIGL
高出325.0%
59.0%
两年增速更快
RIGL
近两年复合增速
25.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.6M | $69.8M |
| 净利润 | $38.1M | $268.1M |
| 毛利率 | 26.9% | 91.5% |
| 营业利润率 | 34.2% | 33.2% |
| 净利率 | 59.0% | 384.0% |
| 营收同比 | 92.8% | 21.2% |
| 净利润同比 | 563.1% | 1769.2% |
| 每股收益（稀释后） | $0.66 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MUXRIGL
| Q4 25 | $64.6M | $69.8M | ||
| Q3 25 | $50.5M | $69.5M | ||
| Q2 25 | $46.7M | $101.7M | ||
| Q1 25 | $35.7M | $53.3M | ||
| Q4 24 | $33.5M | $57.6M | ||
| Q3 24 | $52.3M | $55.3M | ||
| Q2 24 | $47.5M | $36.8M | ||
| Q1 24 | $41.2M | $29.5M |
净利润MUXRIGL
| Q4 25 | $38.1M | $268.1M | ||
| Q3 25 | $-462.0K | $27.9M | ||
| Q2 25 | $3.0M | $59.6M | ||
| Q1 25 | $-6.3M | $11.4M | ||
| Q4 24 | $-8.2M | $14.3M | ||
| Q3 24 | $-2.1M | $12.4M | ||
| Q2 24 | $-13.0M | $-1.0M | ||
| Q1 24 | $-20.4M | $-8.2M |
毛利率MUXRIGL
| Q4 25 | 26.9% | 91.5% | ||
| Q3 25 | 15.5% | 93.2% | ||
| Q2 25 | 26.3% | 95.6% | ||
| Q1 25 | 28.2% | 91.7% | ||
| Q4 24 | 1.1% | 89.9% | ||
| Q3 24 | 26.4% | 85.5% | ||
| Q2 24 | 22.7% | 92.4% | ||
| Q1 24 | 14.6% | 93.1% |
营业利润率MUXRIGL
| Q4 25 | 34.2% | 33.2% | ||
| Q3 25 | -16.7% | 40.9% | ||
| Q2 25 | -7.2% | 60.1% | ||
| Q1 25 | -21.4% | 23.9% | ||
| Q4 24 | -43.4% | 28.9% | ||
| Q3 24 | -0.2% | 25.4% | ||
| Q2 24 | -29.4% | 1.2% | ||
| Q1 24 | -53.3% | -23.6% |
净利率MUXRIGL
| Q4 25 | 59.0% | 384.0% | ||
| Q3 25 | -0.9% | 40.2% | ||
| Q2 25 | 6.5% | 58.6% | ||
| Q1 25 | -17.6% | 21.5% | ||
| Q4 24 | -24.6% | 24.9% | ||
| Q3 24 | -4.0% | 22.5% | ||
| Q2 24 | -27.4% | -2.8% | ||
| Q1 24 | -49.4% | -27.9% |
每股收益（稀释后）MUXRIGL
| Q4 25 | $0.66 | $14.11 | ||
| Q3 25 | $-0.01 | $1.46 | ||
| Q2 25 | $0.06 | $3.28 | ||
| Q1 25 | $-0.12 | $0.63 | ||
| Q4 24 | $-0.15 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $-0.26 | $-0.06 | ||
| Q1 24 | $-0.41 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.1M | $155.0M |
| 总债务越低越好 | $126.2M | $52.5M |
| 股东权益账面价值 | $546.2M | $391.5M |
| 总资产 | $820.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.23× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MUXRIGL
| Q4 25 | $72.1M | $155.0M | ||
| Q3 25 | $75.4M | $137.1M | ||
| Q2 25 | $69.5M | $108.4M | ||
| Q1 25 | $79.3M | $77.1M | ||
| Q4 24 | $15.3M | $77.3M | ||
| Q3 24 | $30.2M | $61.1M | ||
| Q2 24 | $42.6M | $49.1M | ||
| Q1 24 | $22.0M | $49.5M |
总债务MUXRIGL
| Q4 25 | $126.2M | $52.5M | ||
| Q3 25 | $126.0M | $60.0M | ||
| Q2 25 | $125.8M | $60.0M | ||
| Q1 25 | $125.5M | $60.0M | ||
| Q4 24 | $40.0M | $60.0M | ||
| Q3 24 | $31.0M | $60.0M | ||
| Q2 24 | $34.0M | $60.0M | ||
| Q1 24 | $37.0M | $60.0M |
股东权益MUXRIGL
| Q4 25 | $546.2M | $391.5M | ||
| Q3 25 | $488.6M | $117.6M | ||
| Q2 25 | $484.5M | $81.9M | ||
| Q1 25 | $479.8M | $18.6M | ||
| Q4 24 | $495.0M | $3.3M | ||
| Q3 24 | $502.1M | $-14.6M | ||
| Q2 24 | $485.2M | $-29.9M | ||
| Q1 24 | $482.5M | $-31.7M |
总资产MUXRIGL
| Q4 25 | $820.2M | $513.6M | ||
| Q3 25 | $747.6M | $242.5M | ||
| Q2 25 | $735.6M | $206.7M | ||
| Q1 25 | $730.6M | $176.0M | ||
| Q4 24 | $664.6M | $164.0M | ||
| Q3 24 | $667.8M | $139.4M | ||
| Q2 24 | $645.1M | $128.4M | ||
| Q1 24 | $638.7M | $126.5M |
负债/权益比MUXRIGL
| Q4 25 | 0.23× | 0.13× | ||
| Q3 25 | 0.26× | 0.51× | ||
| Q2 25 | 0.26× | 0.73× | ||
| Q1 25 | 0.26× | 3.23× | ||
| Q4 24 | 0.08× | 18.25× | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.08× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MUXRIGL
| Q4 25 | $3.1M | $22.0M | ||
| Q3 25 | $5.2M | $24.0M | ||
| Q2 25 | $478.0K | $30.5M | ||
| Q1 25 | $-1.9M | $-893.0K | ||
| Q4 24 | $-1.2M | $14.5M | ||
| Q3 24 | $23.2M | $21.7M | ||
| Q2 24 | $3.6M | $302.0K | ||
| Q1 24 | $3.9M | $-5.0M |
现金转化率MUXRIGL
| Q4 25 | 0.08× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 0.16× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
